BEAM•benzinga•
Beam Therapeutics Presents Biomarker Data For BEAM-302 Gene Therapy For Inherited Disease
Summary
Beam Therapeutics shared updated BEAM-302 trial data in AATD and plans U.S. site activation following FDA clearance of its IND
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 7, 2025 by benzinga